A Multi-Center Trial of Androgen Suppression With Abiraterone Acetate, Leuprolide, PARP Inhibition and Stereotactic Body Radiotherapy in Prostate Cancer

NCT04194554 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

102

Enrollment

OTHER

Sponsor class

Conditions

Prostate Cancer

Interventions

DRUG: Niraparib
DRUG: Leuprolide
DRUG: Abiraterone Acetate
RADIATION: Stereotactic body radiotherapy (SBRT)

Sponsor

University of Michigan Rogel Cancer Center

Collaborators

[object Object]